Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 39Neoplasm Metastasis 5Prostatic Neoplasms, Castration-Resistant 2Castration-resistant Prostate Cancer 2Thrombocytosis 1Salivary Gland Neoplasms 1Prostate Cancer Metastatic Disease 1Prostate Adenocarcinoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oligometastatic Prostate Carcinoma 1Oligo-metastatic Prostate Carcinoma 1Neoadjuvant Therapy 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Metastatic Hormone-Sensitive Prostate Cance 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1

Interventions

Blood Specimen Collection 9Surveys and Questionnaires 5Magnetic Resonance Spectroscopy 5Biopsy 5Prednisone 4Colonoscopy 4Biopsy, Fine-Needle 4Tomography, X-Ray Computed 3Surgical Procedures, Operative 3Mammography 3Magnetic Resonance Imaging 3Liquid Biopsy 3Lenalidomide 3Interviews as Topic 3Exercise 3Diagnostic Tests, Routine 3Cyclophosphamide 3weifuchun 2pembrolizumab 2obinutuzumab 2Urination 2Preoperative Exercise 2Positron Emission Tomography Computed Tomography 2Observation 2Methods 2Melphalan 2Immunohistochemistry 2Hematologic Tests 2Gemcitabine 2Educational Status 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Disease × abiraterone × Clear all
NCT07299292 2025-12-23

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

SMED Clinical Research

Phase 2 Recruiting
60 enrolled
Genitourinary

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡